Nucleolar size indicates the rapidity of cell proliferation in cancer tissues

Journal of Pathology

Volumn 191, Issue 2, 2000, Pages 181-186

  Derenzini, Massimo ^a   Trerè, Davide ^a   Pession, Annalisa ^a   Govoni, Marzia ^a   Sirri, Valentina ^a   Chieco, Pasquale ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

AgNOR proteins; Cancer cells; Cell proliferation rate; Nucleolus; Quantitation; Ribosome biogenesis

Indexed keywords

ARTICLE; BIOGENESIS; CELL PROLIFERATION; CELL SIZE; GENE DUPLICATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LABELING INDEX; NUCLEOLUS; PRIORITY JOURNAL; RIBOSOME; SILVER STAINING; TRANSCRIPTION REGULATION; TUMOR VOLUME; TUMOR XENOGRAFT; XENOGRAFT;

ANIMALS; BROMODEOXYURIDINE; CELL COUNT; CELL DIVISION; CELL NUCLEOLUS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HUMANS; MALE; MICE; MICE, NUDE; NEUROBLASTOMA; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA POLYMERASE I; SILVER STAINING; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034114866     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V     Document Type: Article

References (27)

1. Pianese G. Beitrag zur Histologie und Aetiologie der Carcinoma. Histologische und experimentelle Untersuchungen. Beitr Pathol Anat Allg Pathol 1896; 142: 1-193.
2. Busch H, Smetana K. Nucleoli of tumor cells. In The Nucleolus, Busch H, Smetana K (eds). Academic Press: New York, 1970; 448-471.
3. Trerè D, Pession A, Derenzini M. The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res 1989; 184: 131-137.
4. Derenzini M, Pession A, Trerè D. The quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest 1990; 63: 137-140.
5. Öfner D, Hittmair A. Marth CR, et al. Relationship between quantity of silver-stained nucleolar organizer region associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract 1992; 188: 742-746.
6. Derenzini M, Sirri V, Trerè D, Ochs R. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995; 73: 1-6.
7. Derenzini M, Trerè D, Pession A, Montanaro L, Sirri V, Ochs RL. Nucleolar function and size in cancer cells. Am J Pathol 1998; 152: 1291-1297.
8. Patterson MK Jr. Measurement of growth and viability of cells in culture. In Methods in Enzymology, Jokoby WB, Pastran IH (eds). Academic Press: New York, 1979; 141-167.
9. Swhartz MA. A biomathematical approach to clinical tumor growth. Cancer 1961; 14: 1272-1294.
10. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem J 1986; 18: 5-14.
11. Öfner D, Bankflavi A, Riehemann K, Bier B, Böcker B, Schmid KW. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues. Mod Pathol 1994; 7: 946-950.
12. Stirpe F, Novello F. Factors affecting the activity of ribonucleic acid polymerase solubilized from rat liver nuclei. Effect on ionic strength, spermine and divalent ions with native and denatured deoxyribonucleic acid. Eur J Biochem 1970; 15: 505-512.
13. Hall PA, Levison DA. Assessment of cell proliferation in histological material. J Clin Pathol 1990; 43: 184-192.
14. Queen CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 1990; 160: 93-102.
15. van Diest P, Brugal G, Baak JPA. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 1998; 51: 716-724.
16. Begg AC, McNally NJ, Schrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620-626.
17. Wilson G, McNally NJ. Measurements of cell proliferation using bromodeoxyuridine. In Assessment of Cell Proliferation in Clinical Practice, Hall PA, Levison DA, Wright NA (eds). Springer-Verlag: Berlin, 1992; 113-140.
18. Aubele M, Biesterfild S, Derenzini M, et al. Guidelines of AgNOR quantitation. Zentralbl Pathol 1994; 140: 107-108.
19. Öfner D, Aubele M, Biesterfeld S, et al. Guidelines of AgNOR quantification - first update. Virchows Arch 1995; 427: 341.
20. Derenzini M, Farabegoli F, Trerè D. Relationship between interphase AgNOR distribution and nucleolar size in cancer cells. Histochem J 1992; 24: 951-956.
21. Lipponen PK, Eskelinen MJ, Nordling S. Nucleolar organizer regions (AgNORs) as predictors in transitional cell bladder cancer. Br J Cancer 1991; 64: 1139-1144.
22. Morita M, Kuwano H, Matsuda H, et al. Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma. Cancer Res 1991; 1: 5339-5341.
23. Kaneko S, Ishida T, Sugio K, Yokoyama H, Sugimachi K. Nucleolar organizer regions as prognostic indicator for stage I non-small cell lung cancer. Cancer Res 1991; 1: 4008-4011.
24. Trerè D, Pession A, Basso G, et al. Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia. Br J Cancer 1994; 70: 1198-1202.
25. Öfner D, Riedmann B, Maier H, et al. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma - correlation with tumour stage and long-term survival. J Pathol 1995; 175: 441-448.
26. Chiusa L, Galliano D, Formiconi A, et al. High and low risk prostate carcinoma determined by histologic grade and proliferative activity. Cancer 1997; 15: 1956-1963.
27. Pich A, Chiusa L, Audisio E, Marmont F. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients. J Clin Oncol 1998; 16: 1512-1518.